FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population

被引:13
作者
Lejeune, Julien [1 ,2 ]
Piegu, Benoit [1 ,2 ]
Gouilleux-Gruart, Valerie [1 ,2 ,3 ]
Ohresser, Marc [1 ,2 ]
Watier, Herve [1 ,2 ,3 ]
Thibault, Gilles [1 ,2 ,3 ]
机构
[1] CNRS, UMR Genet Immunotherapie Chim & Canc 7292, Tours, France
[2] Univ Tours, Tours, France
[3] CHU Tours, Immunol Lab, Tours, France
关键词
receptors for the Fc portion of IgG; immune thrombocytopenic purpura; linkage disequilibrium; FC-GAMMA RECEPTORS; COPY NUMBER VARIATION; NATURAL-KILLER-CELLS; NK CELLS; EXPRESSION; RITUXIMAB; AFFINITY; GENE;
D O I
10.4161/mabs.22287
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The FCGR3A-V158F and FCGR2A-H131R polymorphisms are associated with clinical responses to therapeutic mAbs and with immune thrombocytopenic purpura (ITP). The FCGR2C-ORF/STOP polymorphism, controlling Fc gamma RIIC expression on natural killer cells and therefore Fc gamma RIIC-mediated antibody dependent cell-mediated cytotoxicity, is also associated with ITP. Using a new pyrosequencing assay to determine this polymorphism in a control population, we observed the expected allele frequencies (ORF:12.6%) and percentages of individuals with a single copy (10.0%) or 3 copies (12.1%) of FCGR2C, or with at least one FCGR2C-OR F allele (20.1%). No association of FCGR2C copy number variations with the FCGR3A-V158F or FCGR2A-H131R genotype was detected. More importantly, our results demonstrate a strong and a weaker linkage disequilibrium associating the FCGR2C-ORF allele with the FCGR3A-158V and the FCGR2A-131H allele, respectively.
引用
收藏
页码:784 / 787
页数:4
相关论文
共 24 条
  • [1] Haploview: analysis and visualization of LD and haplotype maps
    Barrett, JC
    Fry, B
    Maller, J
    Daly, MJ
    [J]. BIOINFORMATICS, 2005, 21 (02) : 263 - 265
  • [2] Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
    Bibeau, Frederic
    Lopez-Crapez, Evelyne
    Di Fiore, Frederic
    Thezenas, Simon
    Ychou, Marc
    Blanchard, France
    Lamy, Aude
    Penault-Llorca, Frederique
    Frebourg, Thierry
    Michel, Pierre
    Sabourin, Jean-Christophe
    Boissiere-Michot, Florence
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) : 1122 - 1129
  • [3] Functional and clinical consequences of Fc receptor polymorphic and copy number variants
    Bournazos, S.
    Woof, J. M.
    Hart, S. P.
    Dransfield, I.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 157 (02) : 244 - 254
  • [4] Copy Number Variation at the FCGR Locus Includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B
    Breunis, Willemijn B.
    van Mirre, Edwin
    Geissler, Judy
    Laddach, Nadja
    Wolbink, Gertjan
    van der Schoot, Ellen
    de Haas, Masja
    de Boer, Martin
    Roos, Dirk
    Kuijpers, Taco W.
    [J]. HUMAN MUTATION, 2009, 30 (05) : E640 - E650
  • [5] Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura
    Breunis, Willernijn B.
    van Mirre, Edwin
    Bruin, Marrie
    Geissler, Judy
    de Boer, Martin
    Peters, Marjolein
    Roos, Dirk
    de Haas, Masja
    Koene, Harry R.
    Kuijpers, Taco W.
    [J]. BLOOD, 2008, 111 (03) : 1029 - 1038
  • [6] Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses
    Bruhns, Pierre
    Iannascoli, Bruno
    England, Patrick
    Mancardi, David A.
    Fernandez, Nadine
    Jorieux, Sylvie
    Daeron, Marc
    [J]. BLOOD, 2009, 113 (16) : 3716 - 3725
  • [7] Fcγ receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura
    Carcao, MD
    Blanchette, VS
    Wakefield, CD
    Stephens, D
    Ellis, J
    Matheson, K
    Denomme, GA
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (01) : 135 - 141
  • [8] Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
    Cartron, G
    Dacheux, L
    Salles, G
    Solal-Celigny, P
    Bardos, P
    Colombat, P
    Watier, H
    [J]. BLOOD, 2002, 99 (03) : 754 - 758
  • [9] FcγRIIIa expression is not increased on natural killer cells expressing the FcγRIIIa-158V allotype
    Congy-Jolivet, Nicolas
    Bolzec, Armelle
    Ternant, David
    Ohresser, Marc
    Watier, Herve
    Thibault, Gilles
    [J]. CANCER RESEARCH, 2008, 68 (04) : 976 - 980
  • [10] Rituximab-dependent cytotoxicity by natural killer cells:: Influence of FCGR3A polymorphism on the concentration-effect relationship
    Dall'Ozzo, S
    Tartas, S
    Paintaud, G
    Cartron, G
    Colombat, P
    Bardos, P
    Watier, H
    Thibault, G
    [J]. CANCER RESEARCH, 2004, 64 (13) : 4664 - 4669